Abstract

Effect of two different doses of solifenacin succinate therapy (5 mg, 10 mg) for the treatment of ureteral stent (Double J) related symptoms in comparison to placebo

Highlights

  • The double-J ureteral stent is widely used in the endourologic surgery to treat or prevent ureteral obstruction [1]

  • Some of the patients might suffer from stent-related morbidities, such as lower urinary tract symptoms (LUTS), stent-related body pain and hematuria

  • The mean age was similar between three groups

Read more

Summary

Introduction

The double-J ureteral stent is widely used in the endourologic surgery to treat or prevent ureteral obstruction [1]. Some of the patients might suffer from stent-related morbidities, such as lower urinary tract symptoms (LUTS), stent-related body pain and hematuria. These side effects are annoying and might have an adverse effect on quality of life (QoL) and sexual performance for both genders [2,3,4]. This study aimed to assess the effectiveness and safety of solifenacin in treating double-J stent-related symptoms after uncomplicated ureteroscopic lithotripsy (URSL). Double-J ureteral stent is widely used in the endourologic surgery It might cause some annoying side effects. This study aimed to evaluate the effect of two different doses of solifenacin (5 mg, 10 mg) on double-J stent-related symptoms after uncomplicated ureteroscopic lithotripsy

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call